Additional file 1 of Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial
- Resource Type
- Authors
- Jamshidi, Ahmadreza; Vojdanian, Mahdi; Soroush, Mohsen; Akbarian, Mahmoud; Aghaei, Mehrdad; Hajiabbasi, Asghar; Mirfeizi, Zahra; Khabbazi, Alireza; Alishiri, Gholamhosein; Haghighi, Anousheh; Salimzadeh, Ahmad; Karimzadeh, Hadi; Shirani, Fatemeh; Fard, Mohammad Reza Hatef; Nazarinia, MohammadAli; Soroosh, Soosan; Anjidani, Nassim; Gharibdoost, Farhad
- Source
- Subject
- musculoskeletal diseases
sense organs
skin and connective tissue diseases
- Language
Additional file 1. Comparison of the mean percentage change in BMD in the two treatment groups in the PP and ITT populations.